Antenatal Care — MCQs

10 questions

Which of the following is not a high-risk pregnancy?

In pregnancies complicated by intrauterine growth restriction (IUGR) with otherwise reassuring fetal surveillance, what is the recommended gestational age for planned delivery to optimize neonatal outcomes?

In a village health survey, which indicator best reflects the quality of antenatal care services?

A primigravida presents to you with anemia early in her pregnancy. She is 7 weeks pregnant as seen on ultrasound. Her hemoglobin level is 9 g/dL. When should the iron supplements be started for her?

Basanti, a 29-year-old female from Bihar, presents with drug-sensitive tuberculosis. She delivers a baby. All of the following are indicated except:

Under the Anaemia Mukt Bharath initiative, mild to moderate anaemia in pregnant women <34 weeks of gestation is treated using:

What does perinatal mortality include?

Which of the following interventions has the STRONGEST evidence for reducing the risk of preeclampsia in high-risk pregnant women?

A mother delivers in a rural area under the guidance of a skilled care attendant. Which of the following statements is incorrect regarding the care provided by the skilled care attendant at birth?

Q10

Regarding maternal health programs in Community Medicine, which of the following statements about public-private partnership schemes is CORRECT?

Antenatal Care Indian Medical PG Practice Questions and MCQs

Question 1: Which of the following is not a high-risk pregnancy?

A. Age 25-30 years (Correct Answer)
B. Diabetes mellitus
C. Previous history of manual removal of placenta
D. Anemia

Explanation: ***Age 25-30 years*** - An age of **25-30 years** is generally considered the optimal reproductive age range, and pregnancies within this bracket are typically classified as low-risk based on age alone. - This age range carries the lowest statistical risk for both maternal and fetal complications, assuming no other co-morbidities. *Previous history of manual removal of placenta* - A previous history of manual removal of the placenta indicates a risk factor for **recurrent placental retention** or **morbidly adherent placenta** in future pregnancies, making it a high-risk factor. - This history suggests an increased likelihood of complications such as **postpartum hemorrhage** and can influence the management of subsequent deliveries. *Anemia* - **Anemia** in pregnancy, especially severe iron deficiency anemia, is considered a high-risk factor due to increased maternal and fetal morbidity. - It can lead to complications such as **preterm delivery**, **low birth weight**, and difficulties tolerating blood loss during delivery. *Diabetes mellitus* - **Diabetes mellitus**, whether pre-existing or gestational, makes a pregnancy high-risk due to potential adverse effects on both the mother and the fetus. - Risks include **preeclampsia**, **macrosomia**, **neonatal hypoglycemia**, and **congenital anomalies**.

Question 2: In pregnancies complicated by intrauterine growth restriction (IUGR) with otherwise reassuring fetal surveillance, what is the recommended gestational age for planned delivery to optimize neonatal outcomes?

A. 39 weeks
B. 37 weeks
C. 40 weeks
D. 38 weeks (Correct Answer)

Explanation: ***38 weeks*** - For pregnancies complicated by **IUGR (Intrauterine Growth Restriction)** with reassuring fetal surveillance, planned delivery at **38-39 weeks** is recommended by **ACOG guidelines** to optimize neonatal outcomes. - Among the given options, **38 weeks** represents the earliest point in this recommended range, balancing the risks of continued intrauterine compromise with the risks of **prematurity** such as **respiratory distress syndrome**. - This timing is appropriate for **mild to moderate IUGR** without concerning Doppler findings or other complications. *39 weeks* - **39 weeks** is actually within the acceptable range (38-39 weeks) for IUGR delivery per current guidelines. - However, many obstetricians prefer **38 weeks** to minimize the risk of continued **fetal compromise** from **placental insufficiency**, making 38 weeks the more commonly cited benchmark. - The distinction between 38 and 39 weeks is nuanced and depends on individual case factors and surveillance findings. *37 weeks* - Delivery at **37 weeks** is considered **early term** and carries higher risk of **neonatal morbidities**, particularly **respiratory complications** and **hypoglycemia**. - This timing may be appropriate for **severe IUGR** with abnormal **umbilical artery Doppler** findings, **absent or reversed end-diastolic flow**, or other concerning features, but not for routine IUGR with reassuring surveillance. - It is not the standard recommendation for uncomplicated IUGR to optimize outcomes. *40 weeks* - Delivering at **40 weeks** in an IUGR pregnancy is **not recommended** due to increased risk of **stillbirth** and complications from ongoing **placental insufficiency**. - The risks of adverse outcomes escalate with expectant management beyond 38-39 weeks in IUGR pregnancies. - Minimal additional fetal growth occurs beyond this point while risks continue to increase.

Question 3: In a village health survey, which indicator best reflects the quality of antenatal care services?

A. Number of ANC registrations
B. Number of high-risk pregnancies identified
C. Proportion of early ANC registrations (Correct Answer)
D. Percentage of institutional deliveries

Explanation: ***Proportion of early ANC registrations*** - **Early antenatal care (ANC) registration** signifies that pregnant women are accessing care early in their pregnancy, allowing for timely interventions, screening, and health education that improve maternal and fetal outcomes. - This indicator directly reflects the **accessibility and utilization** of quality ANC services from the beginning, which is crucial for comprehensive care. *Number of ANC registrations* - This simply indicates the **total uptake of ANC services**, but doesn't provide insight into the timeliness or quality of the care received. - A high number of registrations could include many late registrations, which would limit the overall effectiveness of ANC. *Number of high-risk pregnancies identified* - While important for targeted interventions, this indicator primarily reflects the **screening capacity** of the health system, not the overall quality or comprehensiveness of routine ANC for all pregnancies. - It doesn't capture whether these high-risk women are receiving adequate follow-up or whether low-risk women are receiving appropriate preventive care. *Percentage of institutional deliveries* - This indicator is an excellent measure of **safe delivery practices** and access to skilled birth attendance, but it reflects the quality of delivery services rather than the quality of antenatal care services themselves. - A woman could have poor ANC but still deliver in an institution, thus it doesn't directly assess the care received *before* delivery.

Question 4: A primigravida presents to you with anemia early in her pregnancy. She is 7 weeks pregnant as seen on ultrasound. Her hemoglobin level is 9 g/dL. When should the iron supplements be started for her?

A. 8 to 10 weeks
B. Immediately upon diagnosis (Correct Answer)
C. After 14 weeks
D. After 20 weeks

Explanation: ***Correct Option: Immediately upon diagnosis*** - **Iron deficiency anemia** in pregnancy (Hb <11 g/dL in first trimester) should be addressed promptly to prevent adverse maternal and fetal outcomes - Initiating treatment at 7 weeks ensures sustained **iron stores** throughout pregnancy - WHO and ACOG guidelines recommend **immediate supplementation** when anemia is diagnosed during antenatal screening - Early treatment prevents worsening due to physiological plasma volume expansion in second trimester *Incorrect Option: 8 to 10 weeks* - Delaying treatment for 1-3 weeks after diagnosis at 7 weeks is not justified medically - Any delay in treatment allows anemia to worsen and depletes maternal iron stores - Recommended practice is **immediate supplementation** if hemoglobin count is less than 11 g/dL during first two antenatal visits *Incorrect Option: After 14 weeks* - Waiting until second trimester (after 14 weeks) would allow the **anemia to worsen**, making it harder to correct before physiological drop in hemoglobin due to plasma volume expansion - Fetal development, particularly **neurological development**, is rapid in first trimester and iron is crucial during this period - Delaying 7 weeks after diagnosis risks maternal complications and suboptimal fetal development *Incorrect Option: After 20 weeks* - Starting supplementation this late (13 weeks after diagnosis) would result in severe maternal iron deficiency - Significant **fetal iron demands** increase by third trimester, making it difficult to replete maternal stores if supplementation starts this late - **Severe anemia** poses risks such as **preterm birth**, low birth weight, and **postpartum hemorrhage**

Question 5: Basanti, a 29-year-old female from Bihar, presents with drug-sensitive tuberculosis. She delivers a baby. All of the following are indicated except:

A. Administer INH to the baby
B. Withhold breast feeding (Correct Answer)
C. Separate the baby from mother immediately
D. Ask mother to ensure proper disposal of sputum

Explanation: ***Withhold breast feeding*** - For mothers with **drug-sensitive tuberculosis**, breastfeeding is **strongly encouraged** by WHO and CDC guidelines as the benefits far outweigh any theoretical risks. - Tuberculosis is **not transmitted through breast milk**, and the nutritional and immunological benefits of breastfeeding are crucial for the newborn. - With appropriate maternal treatment and **INH prophylaxis** for the baby, breastfeeding poses no significant risk and should **never be withheld**. *Administer INH to the baby* - **Isoniazid (INH) prophylaxis** for 6 months is the standard of care for newborns exposed to maternal tuberculosis. - This protects the infant from potential infection via respiratory droplets while the mother is receiving treatment. - After completing prophylaxis, BCG vaccination is given if tuberculosis is excluded. *Separate the baby from mother immediately* - **Immediate routine separation** is generally not recommended for drug-sensitive TB if the mother has been on appropriate treatment for at least 2 weeks and is clinically improving. - **Rooming-in is encouraged** with respiratory hygiene measures (mask wearing, hand hygiene, covering mouth when coughing). - Separation may be considered only for untreated or inadequately treated mothers, or those with multi-drug resistant TB. *Ask mother to ensure proper disposal of sputum* - **Proper sputum disposal** and adherence to respiratory hygiene are essential infection control measures. - This reduces environmental contamination and protects healthcare workers, family members, and the newborn from infectious aerosols. - This is a standard precaution for all tuberculosis patients regardless of drug sensitivity.

Question 6: Under the Anaemia Mukt Bharath initiative, mild to moderate anaemia in pregnant women <34 weeks of gestation is treated using:

A. IM ferric carboxy maltose (FCM)
B. IV iron sucrose for non-compliance with oral tablets
C. 2 iron and folic acid tablets OD+IV iron sucrose
D. 1-2 IFA tablets daily (depending on severity) (Correct Answer)

Explanation: ***1-2 IFA tablets daily (depending on severity)*** - The **Anaemia Mukt Bharat (AMB)** guidelines recommend **oral iron and folic acid (IFA)** supplementation as the primary treatment for mild to moderate anaemia in pregnant women <34 weeks gestation. - **Mild anaemia (Hb 10-10.9 g/dL):** 1 IFA tablet daily (100 mg elemental iron + 500 mcg folic acid) - **Moderate anaemia (Hb 7-9.9 g/dL):** 2 IFA tablets twice daily (total 200 mg elemental iron per day) - Oral IFA is safe, cost-effective, and addresses the underlying nutritional deficiency. *IM ferric carboxy maltose (FCM)* - **Intramuscular (IM) iron** formulations like FCM are generally reserved for cases of severe anaemia, malabsorption, or intolerance to oral iron. - For mild to moderate anaemia, IM iron is not the **first-line treatment** under AMB guidelines due to potential injection site reactions and the effectiveness of oral alternatives. *IV iron sucrose for non-compliance with oral tablets* - **Intravenous (IV) iron sucrose** is indicated for specific situations such as severe anaemia (Hb <7 g/dL), significant malabsorption, documented intolerance, or persistent non-compliance with oral iron. - However, for mild to moderate anaemia, efforts are made to ensure compliance with oral treatment before resorting to **parenteral iron**, particularly given its higher cost and need for administration in a healthcare setting. *2 iron and folic acid tablets OD+IV iron sucrose* - Combining **oral iron tablets with IV iron sucrose** is not recommended for mild to moderate anaemia under AMB guidelines. - This approach would be considered **overtreatment** for mild to moderate anaemia in the absence of severe anaemia or documented failure of oral therapy despite good compliance.

Question 7: What does perinatal mortality include?

A. Deaths after 28 weeks of gestation
B. Deaths within the first 7 days after birth
C. From the period of viability
D. Both late fetal deaths and early neonatal deaths (Correct Answer)

Explanation: ***Both late fetal deaths and early neonatal deaths*** - Perinatal mortality encompasses deaths occurring both in the **late fetal period** (typically after 20-22 weeks of gestation, or commonly defined as 28 weeks or more) and during the **early neonatal period** (the first 7 days of life). - This broad definition helps to capture mortality related to conditions around the time of birth, including those stemming from **pregnancy complications**, labor, delivery, and immediate postnatal adaptation. *Deaths after 28 weeks of gestation* - This describes **late fetal deaths** (stillbirths) but does not include deaths that occur after birth, thus only covering a part of perinatal mortality. - Perinatal mortality is a broader measure that combines both stillbirths and early infant deaths. *Deaths within the first 7 days after birth* - This specifically defines **early neonatal deaths**, which are a component of perinatal mortality, but it excludes fetal deaths. - Perinatal mortality aims to assess factors impacting survival around the time of birth, both before and immediately after. *From the period of viability* - The period of viability refers to when a fetus can survive outside the uterus, which varies (often cited as 20-24 weeks), and would include very premature fetuses, but it isn't an explicit definition of perinatal mortality itself. - This term describes when a fetus is considered potentially viable but does not define the specific timeframe or types of deaths included in perinatal mortality.

Question 8: Which of the following interventions has the STRONGEST evidence for reducing the risk of preeclampsia in high-risk pregnant women?

A. Smoking cessation
B. Low-dose aspirin (75-150 mg daily) (Correct Answer)
C. Calcium supplementation (1.5-2g daily)
D. Regular blood pressure monitoring

Explanation: ***Low-dose aspirin (75-150 mg daily)*** - **Low-dose aspirin** started before 16 weeks of gestation is the **only intervention with robust evidence** for reducing preeclampsia risk in high-risk women (ACOG, WHO, USPSTF recommendations). - Meta-analyses show **17-25% relative risk reduction** in preeclampsia when started early in pregnancy. - Recommended for women with history of preeclampsia, chronic hypertension, diabetes, kidney disease, or multifetal gestation. - Acts by **improving placental perfusion** and reducing thromboxane-mediated vasoconstriction. *Calcium supplementation (1.5-2g daily)* - **Calcium supplementation** shows benefit in **populations with low dietary calcium intake** (typically <600 mg/day). - Less effective in populations with adequate baseline calcium intake (most developed countries). - **WHO recommends** calcium for women in low-calcium settings but **not as first-line** in general high-risk populations. *Smoking cessation* - **Essential for healthy pregnancy** and reduces risks of placental abruption, preterm birth, and IUGR. - While smoking is associated with adverse outcomes, **cessation has not been proven to directly prevent preeclampsia**. - Some studies paradoxically show lower preeclampsia rates in smokers (confounded by lower PlGF levels), but smoking increases overall maternal-fetal morbidity. *Regular blood pressure monitoring* - **Critical for early detection** and management of hypertensive disorders but **does not prevent** their occurrence. - Allows timely intervention to **prevent progression to severe disease** and eclampsia. - Part of routine antenatal care but is a **surveillance measure, not a preventive intervention**.

Question 9: A mother delivers in a rural area under the guidance of a skilled care attendant. Which of the following statements is incorrect regarding the care provided by the skilled care attendant at birth?

A. Start breastfeeding as early as possible
B. Cover the baby's head and body
C. Bathe the baby with warm water (Correct Answer)
D. Clear the eyes with a sterile swab
E. Dry the baby thoroughly and stimulate breathing

Explanation: ***Bathe the baby with warm water*** - **Delaying the first bath** for at least 6-24 hours after birth is recommended to prevent **hypothermia** and promote **skin-to-skin contact** for bonding and breastfeeding. - Early bathing can remove **vernix caseosa**, which provides natural antimicrobial protection and moisturization to the newborn's skin. *Start breastfeeding as early as possible* - **Early initiation of breastfeeding**, ideally within the first hour of birth, is crucial for both mother and baby. - It promotes **uterine contractions** to prevent **postpartum hemorrhage** and provides the newborn with **colostrum**, rich in antibodies. *Cover the baby's head and body* - Covering the newborn's head and body is essential to prevent **heat loss** and maintain a stable **body temperature**, immediately after birth. - Newborns are highly susceptible to **hypothermia** due to their large surface area to mass ratio and immature thermoregulation. *Clear the eyes with a sterile swab* - Clearing the newborn's eyes with a sterile swab is a standard part of immediate newborn care to remove any **mucus or blood** that might have entered during delivery. - This helps prevent **ophthalmia neonatorum**, especially if the mother has an infection like gonorrhea or chlamydia. *Dry the baby thoroughly and stimulate breathing* - **Drying the baby immediately** after birth is a critical first step in newborn resuscitation and care. - It helps prevent **hypothermia** and provides **tactile stimulation** to initiate breathing and crying, which is essential for transitioning from fetal to neonatal circulation.

Question 10: Regarding maternal health programs in Community Medicine, which of the following statements about public-private partnership schemes is CORRECT?

A. It is a voluntary scheme wherein any obstetrician, maternity home, nursing home, MBBS doctor can provide safe motherhood services (Correct Answer)
B. The enrolled doctors must provide iron and folic acid tablets out of their pocket free to the beneficiaries
C. The TT injections are provided by the District Medical Officers to the enrolled doctors for free administration to the beneficiaries
D. To join the Vandemataram Scheme, the facility must have resources for caesarean section

Explanation: ***Correct: Statement 1 - It is a voluntary scheme wherein any obstetrician, maternity home, nursing home, MBBS doctor can provide safe motherhood services.*** - **Public-private partnership (PPP) schemes** in maternal health, such as those under **Janani Suraksha Yojana (JSY)** and related initiatives, are designed with **voluntary participation** as a cornerstone. - This allows qualified private providers including **obstetricians, maternity homes, nursing homes, and MBBS doctors** to participate, thereby expanding access to safe motherhood services. - The voluntary nature encourages broader engagement of the private sector in public health objectives. *Incorrect: Statement 2 - The enrolled doctors must provide iron and folic acid tablets out of their pocket free to the beneficiaries.* - This is **incorrect**. In PPP maternal health programs, the government typically **supplies essential supplements** like **iron and folic acid (IFA)** tablets or provides reimbursement. - Requiring private providers to bear these costs out-of-pocket would be a significant **disincentive to participation** and contradict the partnership model. - The scheme aims to expand access while sharing resources between government and private sectors. *Incorrect: Statement 3 - The TT injections are provided by the District Medical Officers to the enrolled doctors for free administration to the beneficiaries.* - This statement is **partially correct in principle but not universally applicable** to all PPP maternal health schemes. - While government supply of **tetanus toxoid (TT)** vaccines to private facilities occurs in some programs, the specific mechanism of supply through District Medical Officers to enrolled private doctors is **not a standard feature** across all PPP schemes. - Many private providers source their own vaccines, with reimbursement mechanisms varying by scheme. *Incorrect: Statement 4 - To join the Vandemataram Scheme, the facility must have resources for caesarean section.* - This is **incorrect**. The **Vande Mataram Scheme** (integrated into broader maternal health initiatives) does **not mandate** that all participating facilities have **cesarean section capabilities**. - Smaller private clinics and individual practitioners can participate by providing **basic antenatal, natal, and postnatal care** services. - High-risk cases requiring C-sections are referred to facilities equipped for surgical interventions, following a **tiered care model**.

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free